This axis not only enhanced GBM cell proliferation, migration, and invasion but also enabled soluble ENO1 and its downstream metabolite S1P to synergistically polarize TAMs toward an immunosuppressive M2 phenotype, thereby fostering a chemoresistant TME through pro-inflammatory chemokines and cytokines secretion. This evidence concerns the gene ENO1 and glioblastoma.